Cargando…

The Pathological G51D Mutation in Alpha-Synuclein Oligomers Confers Distinct Structural Attributes and Cellular Toxicity

A wide variety of oligomeric structures are formed during the aggregation of proteins associated with neurodegenerative diseases. Such soluble oligomers are believed to be key toxic species in the related disorders; therefore, identification of the structural determinants of toxicity is of upmost im...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Catherine K., Castellana-Cruz, Marta, Chen, Serene W., Du, Zhen, Meisl, Georg, Levin, Aviad, Mannini, Benedetta, Itzhaki, Laura S., Knowles, Tuomas P. J., Dobson, Christopher M., Cremades, Nunilo, Kumita, Janet R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879557/
https://www.ncbi.nlm.nih.gov/pubmed/35209093
http://dx.doi.org/10.3390/molecules27041293
_version_ 1784658919978696704
author Xu, Catherine K.
Castellana-Cruz, Marta
Chen, Serene W.
Du, Zhen
Meisl, Georg
Levin, Aviad
Mannini, Benedetta
Itzhaki, Laura S.
Knowles, Tuomas P. J.
Dobson, Christopher M.
Cremades, Nunilo
Kumita, Janet R.
author_facet Xu, Catherine K.
Castellana-Cruz, Marta
Chen, Serene W.
Du, Zhen
Meisl, Georg
Levin, Aviad
Mannini, Benedetta
Itzhaki, Laura S.
Knowles, Tuomas P. J.
Dobson, Christopher M.
Cremades, Nunilo
Kumita, Janet R.
author_sort Xu, Catherine K.
collection PubMed
description A wide variety of oligomeric structures are formed during the aggregation of proteins associated with neurodegenerative diseases. Such soluble oligomers are believed to be key toxic species in the related disorders; therefore, identification of the structural determinants of toxicity is of upmost importance. Here, we analysed toxic oligomers of α-synuclein and its pathological variants in order to identify structural features that could be related to toxicity and found a novel structural polymorphism within G51D oligomers. These G51D oligomers can adopt a variety of β-sheet-rich structures with differing degrees of α-helical content, and the helical structural content of these oligomers correlates with the level of induced cellular dysfunction in SH-SY5Y cells. This structure–function relationship observed in α-synuclein oligomers thus presents the α-helical structure as another potential structural determinant that may be linked with cellular toxicity in amyloid-related proteins.
format Online
Article
Text
id pubmed-8879557
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88795572022-02-26 The Pathological G51D Mutation in Alpha-Synuclein Oligomers Confers Distinct Structural Attributes and Cellular Toxicity Xu, Catherine K. Castellana-Cruz, Marta Chen, Serene W. Du, Zhen Meisl, Georg Levin, Aviad Mannini, Benedetta Itzhaki, Laura S. Knowles, Tuomas P. J. Dobson, Christopher M. Cremades, Nunilo Kumita, Janet R. Molecules Article A wide variety of oligomeric structures are formed during the aggregation of proteins associated with neurodegenerative diseases. Such soluble oligomers are believed to be key toxic species in the related disorders; therefore, identification of the structural determinants of toxicity is of upmost importance. Here, we analysed toxic oligomers of α-synuclein and its pathological variants in order to identify structural features that could be related to toxicity and found a novel structural polymorphism within G51D oligomers. These G51D oligomers can adopt a variety of β-sheet-rich structures with differing degrees of α-helical content, and the helical structural content of these oligomers correlates with the level of induced cellular dysfunction in SH-SY5Y cells. This structure–function relationship observed in α-synuclein oligomers thus presents the α-helical structure as another potential structural determinant that may be linked with cellular toxicity in amyloid-related proteins. MDPI 2022-02-15 /pmc/articles/PMC8879557/ /pubmed/35209093 http://dx.doi.org/10.3390/molecules27041293 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Xu, Catherine K.
Castellana-Cruz, Marta
Chen, Serene W.
Du, Zhen
Meisl, Georg
Levin, Aviad
Mannini, Benedetta
Itzhaki, Laura S.
Knowles, Tuomas P. J.
Dobson, Christopher M.
Cremades, Nunilo
Kumita, Janet R.
The Pathological G51D Mutation in Alpha-Synuclein Oligomers Confers Distinct Structural Attributes and Cellular Toxicity
title The Pathological G51D Mutation in Alpha-Synuclein Oligomers Confers Distinct Structural Attributes and Cellular Toxicity
title_full The Pathological G51D Mutation in Alpha-Synuclein Oligomers Confers Distinct Structural Attributes and Cellular Toxicity
title_fullStr The Pathological G51D Mutation in Alpha-Synuclein Oligomers Confers Distinct Structural Attributes and Cellular Toxicity
title_full_unstemmed The Pathological G51D Mutation in Alpha-Synuclein Oligomers Confers Distinct Structural Attributes and Cellular Toxicity
title_short The Pathological G51D Mutation in Alpha-Synuclein Oligomers Confers Distinct Structural Attributes and Cellular Toxicity
title_sort pathological g51d mutation in alpha-synuclein oligomers confers distinct structural attributes and cellular toxicity
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879557/
https://www.ncbi.nlm.nih.gov/pubmed/35209093
http://dx.doi.org/10.3390/molecules27041293
work_keys_str_mv AT xucatherinek thepathologicalg51dmutationinalphasynucleinoligomersconfersdistinctstructuralattributesandcellulartoxicity
AT castellanacruzmarta thepathologicalg51dmutationinalphasynucleinoligomersconfersdistinctstructuralattributesandcellulartoxicity
AT chenserenew thepathologicalg51dmutationinalphasynucleinoligomersconfersdistinctstructuralattributesandcellulartoxicity
AT duzhen thepathologicalg51dmutationinalphasynucleinoligomersconfersdistinctstructuralattributesandcellulartoxicity
AT meislgeorg thepathologicalg51dmutationinalphasynucleinoligomersconfersdistinctstructuralattributesandcellulartoxicity
AT levinaviad thepathologicalg51dmutationinalphasynucleinoligomersconfersdistinctstructuralattributesandcellulartoxicity
AT manninibenedetta thepathologicalg51dmutationinalphasynucleinoligomersconfersdistinctstructuralattributesandcellulartoxicity
AT itzhakilauras thepathologicalg51dmutationinalphasynucleinoligomersconfersdistinctstructuralattributesandcellulartoxicity
AT knowlestuomaspj thepathologicalg51dmutationinalphasynucleinoligomersconfersdistinctstructuralattributesandcellulartoxicity
AT dobsonchristopherm thepathologicalg51dmutationinalphasynucleinoligomersconfersdistinctstructuralattributesandcellulartoxicity
AT cremadesnunilo thepathologicalg51dmutationinalphasynucleinoligomersconfersdistinctstructuralattributesandcellulartoxicity
AT kumitajanetr thepathologicalg51dmutationinalphasynucleinoligomersconfersdistinctstructuralattributesandcellulartoxicity
AT xucatherinek pathologicalg51dmutationinalphasynucleinoligomersconfersdistinctstructuralattributesandcellulartoxicity
AT castellanacruzmarta pathologicalg51dmutationinalphasynucleinoligomersconfersdistinctstructuralattributesandcellulartoxicity
AT chenserenew pathologicalg51dmutationinalphasynucleinoligomersconfersdistinctstructuralattributesandcellulartoxicity
AT duzhen pathologicalg51dmutationinalphasynucleinoligomersconfersdistinctstructuralattributesandcellulartoxicity
AT meislgeorg pathologicalg51dmutationinalphasynucleinoligomersconfersdistinctstructuralattributesandcellulartoxicity
AT levinaviad pathologicalg51dmutationinalphasynucleinoligomersconfersdistinctstructuralattributesandcellulartoxicity
AT manninibenedetta pathologicalg51dmutationinalphasynucleinoligomersconfersdistinctstructuralattributesandcellulartoxicity
AT itzhakilauras pathologicalg51dmutationinalphasynucleinoligomersconfersdistinctstructuralattributesandcellulartoxicity
AT knowlestuomaspj pathologicalg51dmutationinalphasynucleinoligomersconfersdistinctstructuralattributesandcellulartoxicity
AT dobsonchristopherm pathologicalg51dmutationinalphasynucleinoligomersconfersdistinctstructuralattributesandcellulartoxicity
AT cremadesnunilo pathologicalg51dmutationinalphasynucleinoligomersconfersdistinctstructuralattributesandcellulartoxicity
AT kumitajanetr pathologicalg51dmutationinalphasynucleinoligomersconfersdistinctstructuralattributesandcellulartoxicity